Oncology Nursing News®

Adverse Event Management

Managing irAEs is a

Managing irAEs is a "Dynamic Discussion"

BY BRIELLE BENYON AND GINA COLUMBUS

Luspatercept Reduces Anemia in Patients With MDS

Luspatercept Reduces Anemia in Patients With MDS

BY BRITTANY COTE

Nurses: Frequently Discuss AEs With Your Patients

Nurses: Frequently Discuss AEs With Your Patients

BY MADELINE KUIPER, MSN, RN, OCN

Patients' Opioid Self-Management Poses Risks

Patients' Opioid Self-Management Poses Risks

BY BRIELLE BENYON

FDA Accepts BLA for Eflapegrastim for Chemo-Induced Neutropenia

FDA Accepts BLA for Eflapegrastim for Chemo-Induced Neutropenia

BY GINA COLUMBUS

AE Management Could Affect Compliance in Breast Cancer Treatment

AE Management Could Affect Compliance in Breast Cancer Treatment

BY MADELINE KUIPER, MSN, RN, OCN

Immunotherapy-Related Colitis: A 'Hot Topic'

Immunotherapy-Related Colitis: A 'Hot Topic'

BY YINGHONG WANG, MD, PHD, MS

Reducing Transfusion Burden in Patients With Beta-Thalassemia

Reducing Transfusion Burden in Patients With Beta-Thalassemia

BY LYNNE LEDERMAN, PHD

Early Steroid Use Reduces Cytokine Release Syndrome Risk With Axi-Cel Treatment

Early Steroid Use Reduces Cytokine Release Syndrome Risk With Axi-Cel Treatment

BY WAYNE KUZNAR

FDA Grants Breakthrough Therapy Designation for GVHD Prevention Drug

FDA Grants Breakthrough Therapy Designation for GVHD Prevention Drug

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.